公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2024 | An algorithm for simplified hepatitis C virus treatment with non-specialist care based on nation-wide data from Taiwan | Yu, Ming-Lung; Tai, Chi-Ming; Mo, Lein-Ray; Kuo, Hsing-Tao; Huang, Chung-Feng; Tseng, Kuo-Chih; Lo, Ching-Chu; Bair, Ming-Jong; Wang, Szu-Jen; Huang, Jee-Fu; Yeh, Ming-Lun; Chen, Chun-Ting; Tsai, Ming-Chang; Huang, Chien-Wei; Lee, Pei-Lun; Yang, Tzeng-Hue; Huang, Yi-Hsiang; Chong, Lee-Won; Chen, Chien-Lin; Yang, Chi-Chieh; Hung, Chao-Hung; Yang, Sheng-Shun; Cheng, Pin-Nan; Hsieh, Tsai-Yuan; Hu, Jui-Ting; Wu, Wen-Chih; Cheng, Chien-Yu; Chen, Guei-Ying; Zhou, Guo-Xiong; Tsai, Wei-Lun; Kao, Chien-Neng; Lin, Chih-Lang; Wang, Chia-Chi; Lin, Ta-Ya; Lin, Chih-Lin; Su, Wei-Wen; Lee, Tzong-Hsi; Chang, Te-Sheng; CHUN-JEN LIU ; Dai, Chia-Yen; Chen, Chi-Yi; JIA-HORNG KAO ; Lin, Han-Chieh; Chuang, Wan-Long; Peng, Cheng-Yuan | Hepatology international | | | |
2024 | Artificial intelligence predicts direct-acting antivirals failure among hepatitis C virus patients: A nationwide hepatitis C virus registry program | Lu, Ming-Ying; Huang, Chung-Feng; Hung, Chao-Hung; Tai, Chi-Ming; Mo, Lein-Ray; Kuo, Hsing-Tao; Tseng, Kuo-Chih; Lo, Ching-Chu; Bair, Ming-Jong; Wang, Szu-Jen; Huang, Jee-Fu; Yeh, Ming-Lun; Chen, Chun-Ting; Tsai, Ming-Chang; Huang, Chien-Wei; Lee, Pei-Lun; Yang, Tzeng-Hue; Huang, Yi-Hsiang; Chong, Lee-Won; Chen, Chien-Lin; Yang, Chi-Chieh; Yang, Sheng-Shun; Cheng, Pin-Nan; Hsieh, Tsai-Yuan; Hu, Jui-Ting; Wu, Wen-Chih; Cheng, Chien-Yu; Chen, Guei-Ying; Zhou, Guo-Xiong; Tsai, Wei-Lun; Kao, Chien-Neng; Lin, Chih-Lang; Wang, Chia-Chi; Lin, Ta-Ya; Lin, Chih-Lin; Su, Wei-Wen; Lee, Tzong-Hsi; Chang, Te-Sheng; CHUN-JEN LIU ; Dai, Chia-Yen; JIA-HORNG KAO ; Lin, Han-Chieh; Chuang, Wan-Long; Peng, Cheng-Yuan; Tsai, Chun-Wei-; Chen, Chi-Yi; Yu, Ming-Lung | Clinical and molecular hepatology | | | |
2021 | Drug Resistance Profile and Clinical Features for Hepatitis C Patients Experiencing DAA Failure in Taiwan | CHUN-MING HONG ; Lin, You-Yu; CHUN-JEN LIU ; Lai, Ya-Yun; Shiou-Hwei Yeh ; HUNG-CHIH YANG ; JIA-HORNG KAO ; SHIH-JER HSU ; Huang, Yi-Hsiang; Yang, Sheng-Shun; Kuo, Hsing-Tao; Cheng, Pin-Nan; Yu, Ming-Lung; PEI-JER CHEN | Viruses | 5 | 2 | |
2022 | Hepatitis C virus reinfection in patients on haemodialysis after achieving sustained virologic response with antiviral treatment | CHEN-HUA LIU ; Peng, Cheng-Yuan; Kao, Wei-Yu; Yang, Sheng-Shun; Shih, Yu-Lueng; CHIH-YUAN LEE ; MENG-KUN TSAI ; Lee, Chih-Yuan; Chang, Chun-Chao; Wu, Jo-Hsuan; CHUN-JEN LIU ; TUNG-HUNG SU ; TAI-CHUNG TSENG ; PEI-JER CHEN ; JIA-HORNG KAO | Alimentary pharmacology & therapeutics | 11 | 9 | |
2022 | Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR Study | CHEN-HUA LIU ; HSIN-YUN SUN ; Peng, Cheng-Yuan; SZU-MIN HSIEH ; Yang, Sheng-Shun; Kao, Wei-Yu; Shih, Yu-Lueng; Lin, Chih-Lin; CHUN-JEN LIU ; WANG-HUEI SHENG ; Lo, Yi-Chun; Liu, Wen-Chun; Wu, Jo-Hsuan; TUNG-HUNG SU ; TAI-CHUNG TSENG ; PEI-JER CHEN ; CHIEN-CHING HUNG ; JIA-HORNG KAO | Open forum infectious diseases | 9 | 7 | |
2014 | Inosine Triphosphatase and Interleukin 28B Genetic Variants to Predict Sustained Virologic Response in Hemodialysis Patients with Hepatitis C Virus Genotype 1 or 2 Infection who Received Peginterferon alfa-2a plus Low-Dose Ribavirin: Data Analysis from HELPER-1 and HELPER-2 Trials | Liu, Chen-Hua; Liu, Chun-Jen; Huang, Chung-Feng; Lin, Jou-Wei; Dai, Chia-Yen; Liang, Cheng-Chao; Huang, Jee-Fu; Hung, Peir-Haur; Tsai, Hung-Bin; Tsai, Meng-Kun; Lee, Chih-Yuan; Chen, Shih-I; Yang, Sheng-Shun; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Yu, Ming-Lung; Kao, Jia-Horng | Hepatology | | | |
2012 | Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin | CHEN-HUA LIU ; Liang, Cheng-Chao; CHUN-JEN LIU ; TAI-CHUNG TSENG ; Lin, Chih-Lin; Yang, Sheng-Shun; TUNG-HUNG SU ; JOU-WEI LIN ; Chen, Jun-Herng; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Antiviral therapy | 21 | 22 | |
2006 | Intraoperative Ultrasonography Reduces Jaundice after Resection for Hepatocellular Carcinoma: 10 Years Retrospective Analysis | YANG, SHENG-SHUN; HU, JUI-TING; HUANG, C- S; CHEN, KAI-MO; CHEN, DING-SHINN | LIVER INTERNATIONAL | | | |
2015 | Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naïve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial | CHEN-HUA LIU ; Huang, Chung-Feng; CHUN-JEN LIU ; Dai, Chia-Yen; Huang, Jee-Fu; JOU-WEI LIN ; Liang, Cheng-Chao; Yang, Sheng-Shun; CHIH-HUNG LIN ; TUNG-HUNG SU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; Chuang, Wan-Long; JIA-HORNG KAO ; Yu, Ming-Lung | Scientific reports | 8 | 8 | |
2015 | Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: a randomized trial | CHEN-HUA LIU ; Huang, Chung-Feng; CHUN-JEN LIU ; Dai, Chia-Yen; Huang, Jee-Fu; JOU-WEI LIN ; Liang, Cheng-Chao; Yang, Sheng-Shun; Lin, Chih-Lin; TUNG-HUNG SU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; Chuang, Wan-Long; JIA-HORNG KAO ; Yu, Ming-Lung | Scientific reports | 7 | 7 | |
2013 | Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial | CHEN-HUA LIU ; Huang, Chung-Feng; CHUN-JEN LIU ; Dai, Chia-Yen; Liang, Cheng-Chao; Huang, Jee-Fu; Hung, Peir-Haur; HUNG-BIN TSAI ; MENG-KUN TSAI ; Chen, Shih-I; JOU-WEI LIN ; Yang, Sheng-Shun; TUNG-HUNG SU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; Chuang, Wan-Long; Yu, Ming-Lung; JIA-HORNG KAO | Annals of internal medicine | 85 | 77 | |
2014 | Reduction of hepatocellular carcinoma in hepatitis B-related cirrhosis patients with long-term entecavir therapy - A follow-up report of C-TEAM study | Su, Tung-Hung; Hu, Tsung-Hui; Chen, Chi-Yi; Huang, Yi-Hsiang; Chuang, Wan-Long; Lin, Chun-Che; Wang, Chia-Chi; Su, Wei-Wen; Peng, Cheng-Yuan; Chien, Rong-Nan; Mo, Lein-Ray; Huang, Yi-Wen; Chen, Ming-Yao; Lin, Chih-Lin; Chen, Tsung-Ming; Wang, Horng-Yuan; Tseng, Kuo-Chih; Yang, Sheng-Shun; Hsu, Shih-Jer; Suk, Fat-Moon; Hu, Chi-Tan; Hsieh, Tsai-Yuan; Ming-jong, Bair; Liang, Cheng-Chao; Tseng, Tai-Chung; Chen, Chi-Ling; Kao, Jia-Horng | Hepatology | | | |
2014 | Reduction of hepatocellular carcinoma in hepatitis B-related cirrhosis patients with long-term entecavir therapy - A follow-up report of C-TEAM study | Su, Tung-Hung; Hu, Tsung-Hui; Chen, Chi-Yi; Huang, Yi-Hsiang; Chuang, Wan-Long; Lin, Chun-Che; Wang, Chia-Chi; Su, Wei-Wen; Peng, Cheng-Yuan; Chien, Rong-Nan; Mo, Lein-Ray; Huang, Yi-Wen; Chen, Ming-Yao; Lin, Chih-Lin; Chen, Tsung-Ming; Wang, Horng-Yuan; Tseng, Kuo-Chih; Yang, Sheng-Shun; Hsu, Shih-Jer; Suk, Fat-Moon; Hu, Chi-Tan; Hsieh, Tsai-Yuan; Ming-jong, Bair; Liang, Cheng-Chao; Tseng, Tai-Chung; Chen, Chi-Ling; Kao, Jia-Horng | Hepatology | | | |
2013 | Reduction of hepatocellular carcinoma in hepatitis B-related cirrhosis patients with long-term entecavir therapy - An interim report of C-TEAM study | Su, Tung-Hung; Hu, Tsung-Hui; Lin, Chun-Che; Peng, Cheng-Yuan; Chuang, Wan-Long; Chen, Chi-Yi; Wang, Chia-Chi; Chien, Rong-Nan; Huang, Yi-Hsiang; Lin, Chih-Lin; Yang, Sheng-Shun; Huang, Yi-Wen; Hsu, Shih-Jer; Wang, Horng-Yuan; Mo, Lein-Ray; Ming-jong, Bair; Liang, Cheng-Chao; Tseng, Tai-Chung; Chen, Chi-Ling; Lei, Yung-Chao; Kao, Jia-Horng | Hepatology | | | |
2013 | Reduction of hepatocellular carcinoma in hepatitis B-related cirrhosis patients with long-term entecavir therapy - An interim report of C-TEAM study | Su, Tung-Hung; Hu, Tsung-Hui; Lin, Chun-Che; Peng, Cheng-Yuan; Chuang, Wan-Long; Chen, Chi-Yi; Wang, Chia-Chi; Chien, Rong-Nan; Huang, Yi-Hsiang; Lin, Chih-Lin; Yang, Sheng-Shun; Huang, Yi-Wen; Hsu, Shih-Jer; Wang, Horng-Yuan; Mo, Lein-Ray; Ming-jong, Bair; Liang, Cheng-Chao; Tseng, Tai-Chung; Chen, Chi-Ling; Lei, Yung-Chao; Kao, Jia-Horng | Hepatology | | | |
2015 | Reduction of hepatocellular carcinoma in hepatitis B-related cirrhosis patients with long-term entecavir therapy-The final report of C-TEAM study | Su, Tung-Hung; Hu, Tsung-Hui; Chen, Chi-Yi; Huang, Yi-Hsiang; Chuang, Wan-Long; Lin, Chun-Che; Wang, Chia-Chi; Su, Wei-Wen; Chen, Ming-Yao; Peng, Cheng-Yuan; Chien, Rong-Nan; Huang, Yi-Wen; Wang, Horng-Yuan; Lin, Chih-Lin; Yang, Sheng-Shun; Chen, Tsung-Ming; Mo, Lein-Ray; Hsu, Shih-Jer; Tseng, Kuo-Chih; Hsieh, Tsai-Yuan; Suk, Fat-Moon; Hu, Chi-Tan; Ming-Jong, Bair; Liang, Cheng-Chao; Tseng, Tai-Chung; Chen, Chi-Ling; Kao, Jia-Horng | Hepatology | | | |
2015 | Reduction of hepatocellular carcinoma in hepatitis B-related cirrhosis patients with long-term entecavir therapy-The final report of C-TEAM study | Su, Tung-Hung; Hu, Tsung-Hui; Chen, Chi-Yi; Huang, Yi-Hsiang; Chuang, Wan-Long; Lin, Chun-Che; Wang, Chia-Chi; Su, Wei-Wen; Chen, Ming-Yao; Peng, Cheng-Yuan; Chien, Rong-Nan; Huang, Yi-Wen; Wang, Horng-Yuan; Lin, Chih-Lin; Yang, Sheng-Shun; Chen, Tsung-Ming; Mo, Lein-Ray; Hsu, Shih-Jer; Tseng, Kuo-Chih; Hsieh, Tsai-Yuan; Suk, Fat-Moon; Hu, Chi-Tan; Ming-Jong, Bair; Liang, Cheng-Chao; Tseng, Tai-Chung; Chen, Chi-Ling; Kao, Jia-Horng | Hepatology | | | |
2021 | Ropeginterferon Alfa-2b administered every two weeks for patients with genotype 2 chronic hepatitis C | SHIH-JER HSU ; Yu, Ming-Lung; Su, Chien-Wei; Peng, Cheng-Yuan; Chien, Rong-Nan; Lin, Hsien-Hong; Lo, Gin-Ho; Su, Wei-Wen; Kuo, Hsing-Tao; Hsu, Chao-Wei; Yang, Sien-Sing; Yang, Sheng-Shun; Tseng, Kuan-Chiao; Qin, Albert; Huang, Yi-Wen; Chuang, Wan-Long | Journal of the Formosan Medical Association = Taiwan yi zhi | 14 | 12 | |
2006 | SECULAR TRENDS AND GEOGRAPHIC VARIATIONS OF HEPATITIS B VIRUS AND HEPATITIS C VIRUS-ASSOCIATED HEPATOCELLULAR CARCINOMA IN TAIWAN | LU, SHENG-NAN; SU, WEI-WEN; YANG, SHENG-SHUN; CHANG, TING-TSUNG; CHENG, KEN-SHENG; WU, JAW-CHING; LIN, HANS, HSIEN-HONG; WU, SHUN-SHENG; LEE, CHUAN-MO; CHANGCHIEN, CHI-SIN; CHEN, CHIEN-JEN; SHEU, JIN-CHUAN; CHEN, DING-SHINN | INTERNATIONAL JOURNAL OF CANCER | | | |
2023 | Sofosbuvir/velpatasvir/voxilaprevir for patients with chronic hepatitis C virus infection previously treated with NS5A direct-acting antivirals: a real-world multicenter cohort in Taiwan | CHEN-HUA LIU ; Peng, Cheng-Yuan; CHUN-JEN LIU ; Chen, Chi-Yi; Lo, Ching-Chu; Tseng, Kuo-Chih; Su, Pei-Yuan; Kao, Wei-Yu; Tsai, Ming-Chang; Tung, Hung-Da; Cheng, Hao-Tsai; Lee, Fu-Jen; Huang, Chia-Sheng; Huang, Ke-Jhang; Shih, Yu-Lueng; Yang, Sheng-Shun; Wu, Jo-Hsuan; Lai, Hsueh-Chou; YU-JEN FANG ; Chen, Po-Yueh; Hwang, Jow-Jyh; Tseng, Chi-Wei; Su, Wei-Wen; Chang, Chun-Chao; Lee, Pei-Lun; Chen, Jyh-Jou; Chang, Chi-Yang; Hsieh, Tsai-Yuan; Chang, Chung-Hsin; Huang, Yi-Jie; JIA-HORNG KAO | Hepatology international | 4 | 4 | |